Coronavirus Infection
198
3
5
115
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
29 trials with published results (15%)
Research Maturity
115 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.1%
28 terminated out of 198 trials
80.4%
-6.1% vs benchmark
14%
27 trials in Phase 3/4
25%
29 of 115 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 115 completed trials
Clinical Trials (198)
SPI-1005 Treatment in Severe COVID-19 Patients
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19
Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Post COVID-19 Biorepository
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Hydroxychloroquine in Outpatient Adults With COVID-19
Study of the Pathogenesis of Olfactory Disorders in COVID-19
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)
COVID-19 Health Professional Impact Study
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
Relative Bioavailability Study of CX2101A for the Treatment of COVID-19
Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
Capturing MultiORgan Effects of COVID-19
Novel Experimental COVID-19 Therapies Affecting Host Response
BCG Vaccine for Health Care Workers as Defense Against COVID 19